Bolis G - Search Results

1

The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocol.

Silvestrini R, Daidone MG, Veneroni S, Benini E, Scarfone G, Zanaboni F, Villa A, Presti M, Danese S, Bolis G. Silvestrini R, et al. Among authors: bolis g. Cancer. 1998 Jan 1;82(1):159-67. Cancer. 1998. PMID: 9428493 Clinical Trial.

2

Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized study.

Bolis G, Scarfone G, Raspagliesi F, Mangili G, Danese S, Scollo P, Lo Russo D, Villa A, Aimone PD, Scambia G. Bolis G, et al. Eur J Cancer. 2010 Nov;46(16):2905-12. doi: 10.1016/j.ejca.2010.06.124. Epub 2010 Jul 29. Eur J Cancer. 2010. PMID: 20673626 Free article. Clinical Trial.

3

Cell kinetics: a prognostic marker in epithelial ovarian cancer.

Silvestrini R, Daidone MG, Bolis G, Fontanelli R, Landoni F, Andreola S, Colombi R. Silvestrini R, et al. Among authors: bolis g. Gynecol Oncol. 1989 Oct;35(1):15-9. doi: 10.1016/0090-8258(89)90003-6. Gynecol Oncol. 1989. PMID: 2676750 Clinical Trial.

4

Response to second-line weekly cisplatin chemotherapy in ovarian cancer previously treated with a cisplatin- or carboplatin-based regimen.

Bolis G, Scarfone G, Luchini L, Ferraris C, Zanaboni F, Presti M, Giardina G, Villa A, Parazzini F. Bolis G, et al. Eur J Cancer. 1994;30A(12):1764-8. doi: 10.1016/0959-8049(94)e0125-n. Eur J Cancer. 1994. PMID: 7880602

5

Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomy.

Bolis G, Villa A, Guarnerio P, Ferraris C, Gavoni N, Giardina G, Melpignano M, Scarfone G, Zanaboni F, Parazzini F. Bolis G, et al. Cancer. 1996 Jan 1;77(1):128-31. doi: 10.1002/(SICI)1097-0142(19960101)77:1<128::AID-CNCR21>3.0.CO;2-6. Cancer. 1996. PMID: 8630918

6

p53 expression, DNA content and cell proliferation in primary and synchronous metastatic lesions from ovarian surface epithelial-stromal tumours.

Daidone MG, Benini E, Valentinis B, Tomasic G, Bolis G, Villa A, Silvestrini R. Daidone MG, et al. Among authors: bolis g. Eur J Cancer. 1996 Jul;32A(8):1388-93. doi: 10.1016/0959-8049(96)00101-3. Eur J Cancer. 1996. PMID: 8869104

7

A phase I-II trial of fixed-dose carboplatin and escalating paclitaxel in advanced ovarian cancer.

Bolis G, Scarfone G, Zanaboni F, Villa A, Presti M, Melpignano M, Ferraris C, Tateo S, Guarnerio P, Gentile A, Parazzini F. Bolis G, et al. Eur J Cancer. 1997 Apr;33(4):592-5. doi: 10.1016/s0959-8049(96)00495-9. Eur J Cancer. 1997. PMID: 9274440 Clinical Trial.

8

Survival and prognostic factors of early ovarian cancer.

Villa A, Parazzini F, Acerboni S, Guarnerio P, Bolis G. Villa A, et al. Among authors: bolis g. Br J Cancer. 1998;77(1):123-4. doi: 10.1038/bjc.1998.19. Br J Cancer. 1998. PMID: 9459156 Free PMC article.

9

Potentials of cell kinetics in the management of patients with ovarian cancers.

Silvestrini R, Daidone MG, Valentinis B, Ferraris C, Di Re E, Raspagliesi F, Landoni F, Scarfone G, Bolis G. Silvestrini R, et al. Among authors: bolis g. Eur J Cancer. 1992;28(2-3):386-90. doi: 10.1016/s0959-8049(05)80059-0. Eur J Cancer. 1992. PMID: 1591051

10

Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin.

Mangioni C, Bolis G, Pecorelli S, Bragman K, Epis A, Favalli G, Gambino A, Landoni F, Presti M, Torri W, et al. Mangioni C, et al. Among authors: bolis g. J Natl Cancer Inst. 1989 Oct 4;81(19):1464-71. doi: 10.1093/jnci/81.19.1464. J Natl Cancer Inst. 1989. PMID: 2674459 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

215 results

Search Page

Filters